Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Horizon Pharma

Horizon Pharma reported $35.99M in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
AbbVie ABBV:US USD 2.77B 2.73B
ALKERMES ALKS:US USD -47494000 26.91M
Amgen AMGN:US USD 2.03B 196M
AstraZeneca AZN:LN USD 2.55B 1.46B
Bausch Health Companies Inc VRX:CN USD 175M 219M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Cara Therapeutics CARA:US USD -27650000 3.66M
Coherus Biosciences CHRS:US USD -67745000 16.25M
Eli Lilly LLY:US USD 1.49B 342.4M
Endo International ENDP:US USD 3.46M 240.32M
Horizon Pharma HZNP:US USD 35.99M 137.94M
Merck & Co MRK:US USD 3.72B 286M
Novartis NOVN:VX USD 2.86B 907M
Pacira PCRX:US USD -20017000 10.12M
Perrigo PRGO:US USD 48.5M 17.5M
Pfizer PFE:US USD 6.79B 1.62B
Revance Therapeutics RVNC:US USD -58032000 86.38M
Supernus Pharmaceuticals SUPN:US USD 5.18M 29.16M
Takeda 4502:JP JPY 88.56B 58.43B
Zoetis ZTS:US USD 697M 105M